Le Lézard
Classified in: Health
Subject: VET

Jon Stewart Joins Wounded Warrior Project Toxic Exposure Discussion


WASHINGTON, June 17, 2020 /PRNewswire/ -- During a recent Washington Post Live event, hosted by columnist David Ignatius, Wounded Warrior Project® (WWP) Government Affairs Director Derek Fronabarger joined toxic exposure activist and comedian Jon Stewart to discuss toxic exposure, burn pits, and the challenges that ill and injured veterans face when it comes to receiving treatment.

"You've got thousands of veterans and their families, once again returning from war, facing a tremendous health crisis due to toxic exposures or traumatic brain injuries and having to battle their own government to get their conditions recognized," Stewart said.

"There's a misperception in the general public that if you're a veteran, you have VA health care, and that's not the case," Fronabarger said. "There is a very complex formula to get into a VA hospital and receive treatment. The difficulty with rare illnesses and toxic exposures is that you have individuals who are around burn pits for a year, who will come home and try to receive benefits, but they were also a smoker. A lot of individuals are being denied access to health care because of those barriers. What we're really pushing for is, while we're looking at the compensation process and looking at the costs, we need to get health care to veterans."

To read the rest of this article and watch the entire discussion, visit our newsroom.

About Wounded Warrior Project
Since 2003, Wounded Warrior Project® (WWP) has been meeting the growing needs of warriors, their families, and caregivers ? helping them achieve their highest ambition. Learn more.

SOURCE Wounded Warrior Project


These press releases may also interest you

at 07:08
Pulnovo Medical Limited, a globally recognized device pioneer in the treatment of Pulmonary Hypertension (PH) and Heart Failure (HF), is pleased to announce the successful initiation and first two patients enrollment for its global multicenter...

at 07:05
Bruker Corporation is pleased to announce the successful installation of a 1.2 GHz NMR spectrometer at the Leibniz Forschungsinstitut für Molekulare Pharmakologie (FMP) in Berlin, accepted in the second quarter of 2024. This ultra-high field NMR...

at 07:05
KORU Medical Systems, Inc. ("KORU Medical" or the "Company"), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today...

at 07:05
Satellos Bioscience Inc. ("Satellos" or the "Company") , a public biotech company developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders, today announced preliminary results from a single case...

at 07:00
ThirtyFiveBio Limited,...

at 07:00
DRI Healthcare Trust (the "Trust"), a global leader in providing financing to advance innovation in the life sciences industry, has acquired a second royalty interest in the worldwide net sales of Xenpozyme (olipudase alfa) from HLS...



News published on and distributed by: